NIT
LXRX icon

NumerixS Investment Technologies’s Lexicon Pharmaceuticals LXRX Stock Holding History

NumerixS Investment Technologies’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,000
Closed -$123K – 1270
2017
Q3 		$123K Sell
10,000
-6,100
-38% -$90.1K 0.03% 676
2017
Q2 		$265K Buy
+16,100
New +$249K 0.04% 542
2017
Q1 		– Sell
-14,202
Closed -$196K – 1273
2016
Q4 		$196K Sell
14,202
-22,800
-62% -$366K 0.02% 675
2016
Q3 		$669K Sell
37,002
-7,371
-17% -$119K 0.09% 291
2016
Q2 		$637K Sell
44,373
-11,700
-21% -$159K 0.09% 325
2016
Q1 		$670K Buy
+56,073
New +$588K 0.08% 373

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $27.8B AUM 39.41% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return

NumerixS Investment Technologies's LXRX Position: Q4 2017 in Review

NumerixS Investment Technologies sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2017, closing a stake of 10,000 shares — an estimated $123K sold.

NumerixS Investment Technologies first reported a position in LXRX in Q1 2016 and held it in 6 quarters. The position peaked at $670K in Q1 2016. 133 funds tracked by Wall St. Rank hold LXRX as of Q4 2017.

  • NumerixS Investment Technologies reported no remaining Lexicon Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • NumerixS Investment Technologies sold 10,000 Lexicon Pharmaceuticals shares in Q4 2017, an estimated $123K.
  • NumerixS Investment Technologies first reported a position in Lexicon Pharmaceuticals in Q1 2016 and held it in 6 quarters.
  • NumerixS Investment Technologies's Lexicon Pharmaceuticals position peaked at $670K in Q1 2016.
  • 133 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2017.

Based on NumerixS Investment Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.